Skip to main content
. 2024 Jul 12;11(7):710. doi: 10.3390/bioengineering11070710

Table 1.

Vedolizumab pharmacokinetic parameters after a single IV dose [29,30].

Vedolizumab Dose [mg/kg]
Healthy Volunteers UC Patients
Parameter 2.0 (n=7) 10.0 (n=7) 2.0 (n=10) 10.0 (n=11)
Cmax [μg/mL] 58.4 243 60.4 291.9
AUC [μg·day/mL] 955 4840 848 4373
t1/2 [day] 14.1 14.8 15.1 20.6
CL [L/day] 0.164 0.139 - -
Vz [L] 3.28 2.73 - -

Cmax, maximum observed serum concentration; AUC, area under the drug concentration–time curve (evaluated until the time of the last quantifiable concentration for healthy volunteers and between days 0 and 14 and days 85 and 99 for UC patients); t1/2, terminal estimation half-life; CL, total clearance; Vz, volume of distribution during the terminal phase.